Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2026, Vol. 31 ›› Issue (10): 1330-1341.doi: 10.12092/j.issn.1009-2501.2026.10.004

Previous Articles    

Mechanistic study on the hepatoprotective effects of Gurigumu-13 Pill against drug-induced liver injury based on metabolomics and metagenomics

Yongqi HUANG1(), Longshan ZHAO1,2, Dongdong ZHAO1, Yukun BO1, Dan YANG1, Jingjing GUO1, Xuemiao YANG3, Yanan LV3, Shumin LI1, Haiyan ZHANG1, Guodong WU1,*(), Ming AN1()   

  1. 1. College of Pharmacy, Baotou Medical College, Inner Mongolia University of Science & Technology, Baotou 014040, Inner Mongolia, China
    2. College of Pharmacy, Shenyang Pharmaceutical University, Shenyang 117004, Liaoning, China
    3. Pharmacy Department, Fourth Hospital of Baotou City, Baotou 014030, Inner Mongolia, China
  • Received:2025-09-30 Revised:2025-12-26 Online:2026-10-26 Published:2026-11-11
  • Contact: Guodong WU E-mail:2961134691@qq.com;wgdzd@126.com;102009113@btmc.edu.cn

Abstract:

AIM: To evaluate the hepatoprotective effect of Gurigumu-13 Pill against acetaminophen (APAP)-induced drug-induced liver injury (DILI) and to explore its underlying mechanisms. METHODS: An APAP-induced DILI model was established in Sprague-Dawley rats by oral administration. Liver injury was assessed by measuring serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, along with histopathological examination. Fecal microbiota composition was analyzed using metagenomic sequencing, and metabolic reprogramming was investigated through untargeted metabolomics. RESULTS: Compared with the model group, Gurigumu-13 Pill significantly reduced serum ALT and AST levels and improved hepatic histopathology. It markedly reversed APAP-induced gut microbiota dysbiosis, enhanced microbial diversity, and modulated metabolic pathways associated with DILI, thereby promoting the restoration of metabolic homeostasis. CONCLUSION: Gurigumu-13 Pill exerts a pronounced hepatoprotective effect by restoring intestinal microecological balance and re-establishing metabolic homeostasis.

Key words: drug-induced liver injury, Gurigumu-13 Pill, metagenomics, metabolomics

CLC Number: